Laurus Labs informs about press release

22 Jul 2019 Evaluate

Laurus Labs has informed about the launch of the generic version of Lyrica®, (pregabalin) Capsules, in all eight commercially available strengths (25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, & 300 mg) in US market along with its exclusive distribution partner Rising Pharmaceuticals, a Rising Pharma Holdings Inc. company. Rising recently received the final approval from the US Food and Drug Administration (FDA) for the Abbreviated New Drug Application (ANDA). A press release to this extent is also attached. 

\The above information is a part of company’s filings submitted to BSE.

Laurus Labs Share Price

610.90 6.70 (1.11%)
21-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.90
Dr. Reddys Lab 1199.30
Cipla 1523.30
Lupin 2115.70
Zydus Lifesciences 918.35
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...